Status:
UNKNOWN
Improving in Vitro Fertilization in Women With Poor Ovarian Response
Lead Sponsor:
Barzilai Medical Center
Conditions:
Poor Ovarian Response
Ovarian Insufficiency
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Improving the results of in vitro fertilization in women with poor ovarian response and early ovarian insufficiency
Detailed Description
BACKGROUND: Mechanical disruption of the Hippo signaling pathway in the ovaries can increase the likelihood of pregnancy and childbirth in women with early ovarian insufficiency. The method may also "...
Eligibility Criteria
Inclusion
- Volunteers with poor ovarian response to standard fertility treatments according to the criteria of the European Fertility Association (ESHRE).
- Diagnosis of early ovarian insufficiency or symptoms that predict early ovarian insufficiency (imminent) seeking to become pregnant.
Exclusion
- Volunteers with
- Severe endometriosis diagnosed with laparoscopy.
- Previous major surgery involving ovaries.
- Ovarian cancer.
- Female reproductive malformations.
- Contraindications for laparoscopic surgery.
Key Trial Info
Start Date :
January 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04024722
Start Date
January 14 2020
End Date
July 31 2022
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barzilay University Medical Center
Ashkelon, Israel